MapLight Therapeutics, Inc. (MPLT)
17.10
-0.12
(-0.70%)
USD |
NASDAQ |
Feb 13, 16:00
17.10
0.00 (0.00%)
After-Hours: 20:00
MapLight Therapeutics Free Cash Flow : -109.22M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CDT Equity, Inc. | -15.13M |
| LENZ Therapeutics, Inc. | -46.16M |
| Liminatus Pharma, Inc. | -10.38M |
| Oruka Therapeutics, Inc. | -84.60M |
| Maze Therapeutics, Inc. | -108.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.79M |
| Cash from Investing (Quarterly) | -135.59M |
| Cash from Financing (Quarterly) | 198.06M |
| Free Cash Flow Per Share (Quarterly) | -0.7013 |
| Free Cash Flow to Equity (Quarterly) | -31.62M |
| Free Cash Flow to Firm (Quarterly) | -31.82M |
| Free Cash Flow Yield | -15.06% |